Catalyst Wire Dossier Catalyst Wire Dossier

Staloral birch pollen extract

birch pollen subcutaneous immunotherapy · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Staloral birch pollen extract, covering 2006-12-19 to 2006-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients [Phase 2]

See pricing